HKTVmall:同一批次口罩测试结果与消委会有出入 成人口罩售价应为65元30片
消委会发表针对口罩评测的报告指,香港电视(01137.HK)旗下HKTVmall口罩在合成血穿透测试中,於80mm Hg的测试仍有2个样本被合成血穿透,表现不理想,而耳带亦容易拉断。而针对报告指公司口罩售价约为100元10片,HKTVmall回应指公司的成人口罩的售价应为65元30片,面层物料为浅绿色,而合成血穿透测试的结果与公司於今年4月及11月透过SGS进行的测试有颇大出入。
公司指於4月时为32个样本进行测试,当中31个样本通过测试;而11月进行了共96个样本测试,测试结果为当中89个均通过测试。以上述的口罩,均为消委会用作测试口罩的相同及同一批次物料,而此项测试一段以32个口罩为测试单位,当中29个样本通过测试即为合格通过测试。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.